Handbook of Urology - Google Books
books.google.co.uk
Tumor sizeis associated with malignant potential in renal cellcarcinoma cases. JUrol 2009;181(5):2033– Rothman J, Egleston B, Wong YN, Iffrig K, ...
Publications Search Results - Healthcare Delivery Research ...
healthcaredelivery.cancer.gov
Nov 29, — Authors: Egleston BL, Uzzo RG, Beck JR, Wong YN. Title: A Simple Method for Evaluating Within Sample Prognostic Balance Achieved by ... › pubsearch › abstract
Theory and Quantitative Methods in Epidemiology (EPID 268)
sph.unc.edu
Sep 30, — Austin SR, Wong YN, Uzzo, RG, Beck JR, Egleston BL. Why summary comorbidity measures such as the Charlson Comorbidity Index and Elixhauser ... › › EPID719_fall2016
table of contents - Pfizer
www.pfizer.com
Wong YN, Hamilton O, Egleston B, et al: Understanding how out-of-pocket ... Wong YN, Egleston BL, Sachdeva K, et al: Cancer patients' trade-offs among.
All web results to the name "Wong Yn"
Bladder Cancer Treatment (PDQ®)–Health Professional ...
www.cancer.gov
· Canter D, Egleston B, Wong YN, et al.: Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis. Urol Oncol 31 (6): , [PUBMED Abstract]
David J. Kaplan, MD - Academic Urology and Urogynecology of AZ
www.academic-urology.com
Kaplan DJ, Kunkle DA, Egleston BL, Wong YN, Saad I, and Uzzo RG. “Kidney Cancer and Competing Causes of Mortality: An Age-based Population Study.” Publication pending. Presentations
Elixhauser Comorbidity Software, Version 3.7
www.hcup-us.ahrq.gov
Austin SR, Wong YN, Uzzo RG, Beck JR, Egleston BL. Why summary comorbidity measures such as the Charlson comorbidity index and Elixhauser score work. Med Care 2015;53(9):e65–72.
Elliot Ross - Publications - Neurotree
neurotree.org
2015, Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, Patel SA, Boraas M, Chang EI, Topham NS, Egleston BL. Time to Surgery and Breast Cancer ... › beta › publications
Eric A. Ross, PhD, ScM - Fox Chase Cancer Center
www.foxchase.org
Egleston BL, Pedraza O, Wong YN, Griffin CL, Ross EA, Beck JR. Temporal trends and characteristics of clinical trials for which only one racial or ethnic ... › eric-ross
Patterns in neurosurgical adverse events and proposed ...
thejns.org
by JM Wong · · Cited by 41 — Stitzenberg KB, Wong YN, Nielsen ME, Egleston BL, Uzzo. RG: Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care. › journals › neurosurg-focus › article-pE1
Publications | mHealth Research Affinitiy Group
mhealth.research.chop.edu
Meropol NJ, Wong YN, Albrecht T, Manne S, Miller SM, Flamm AL, Benson AB 3rd, Buzaglo J, Collins M, Egleston B, Fleisher L, Katz M, Kinzy TG, Liu TM, ... › publications
Brian L. Egleston, MPP, PhD - Fox Chase Cancer Center
www.foxchase.org
Egleston BL, Pedraza O, Wong YN, Griffin CL, Ross EA, Beck JR. Temporal trends and characteristics of clinical trials for which only one racial or ethnic group is ...
Steve Lebovitch
urologicinstituteofnj.com
Steve Lebovitch, M.D Rothman J, Wong YN, Egleston BL, Iffrig K, Lebovitch S, Uzzo RG. Relationship of Tumor Size and Grade in Localized Renal Cell Carcinoma:
SciELO - Brazil - Patient delays and system delays in breast cancer...
www.scielo.br
Bleicher RJ, Ruth K, Sigurdson ER, Ross E, Wong YN, Patel SA, Boraas M, Topham NS, Egleston BL. Preoperative Delays in the US Medicare Population With ...
SciELO - Public Health - Patient delays and system delays in breast...
www.scielosp.org
Bleicher RJ, Ruth K, Sigurdson ER, Ross E, Wong YN, Patel SA, Boraas M, Topham NS, Egleston BL. Preoperative Delays in the US Medicare Population With ...
Renal Cancer | Doctor | Patient
patient.info
Kutikov A, Egleston BL, Wong YN, et al; Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a ...
Related search requests for Wong Yn
Chase Cancer |
People Forename "Wong" (1477) Name |
sorted by relevance / date